In silico identification and in vitro validation of nogalamycin N ‐oxide (NSC116555) as a potent anticancer compound against non–small‐cell lung cancer cells-Reference-Cited by-同舟云学术

In silico identification and in vitro validation of nogalamycin N ‐oxide (NSC116555) as a potent anticancer compound against non–small‐cell lung cancer cells

Published:2018-10-15 Issue:3 Volume:120 Page:3353-3361
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Obounchoey Phongphat¹,Tabtimmai Lueacha²^ORCID,Suphakun Praphasri²,Thongkhao Kannika¹,Eurtivong Chatchakorn²,Gleeson Matthew Paul³^ORCID,Choowongkomon Kiattawee²⁴^ORCID

Affiliation:

1. Interdisciplinary Program in Genetic Engineering Graduate School, Kasetsart University, Chatuchak Bangkok Thailand

2. Department of Biochemistry, Faculty of Science Kasetsart University Bangkok Thailand

3. Department of Biomedical Engineering, Faculty of Engineering King Mongkut's Institute of Technology Ladkrabang Bangkok Thailand

4. Center for Advanced Studies in Nanotechnology for Chemical, Food and Agricultural Industries, KU Institute for Advanced Studies, Kasetsart University Bangkok Thailand

Funder

Kasetsart University

Thailand Research Fund

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27605

Reference32 articles.

1. Cancer 2015

2. 2018 American Cancer Society American Cancer Society Facts & Figures